IGFBP3 and squamous cell carcinoma: In contrast, Igfbp3 KO mice with NQO administration showed significantly increased numbers, volume, and burden of tumor nodules (Figure 2C,D) with SOX2 expression (Figure 2E), a marker of squamous cell carcinoma [40].